AU:COM:EMVISION
EMVision Medical Devices Ltd
- Stock
Last Close
1.93
22/11 05:10
Market Cap
175.98M
Beta: -
Volume Today
21.03K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 2.15K - | -19.02K 984.26% | ||||||
average payables | 330.97K - | 256.67K 22.45% | 185.97K 27.54% | 254.45K 36.82% | 312.07K 22.65% | |||
average receivables | 65.87K - | 40.66K 38.27% | 1.46M - | |||||
book value per share | 0.06 - | 0.10 57.95% | 0.09 8.23% | 0.14 59.44% | 0.09 34.34% | 0.07 30.11% | 0.23 249.72% | |
capex per share | -0.00 - | -0.00 40.01% | -0.00 5.18% | 0.00 255.99% | ||||
capex to depreciation | -0.79 - | -0.55 30.27% | 0.74 234.50% | |||||
capex to operating cash flow | 0.03 - | -0.22 791.27% | -0.05 77.52% | |||||
capex to revenue | ||||||||
cash per share | 0.05 - | 0.09 88.97% | 0.09 5.63% | 0.14 56.92% | 0.09 34.59% | 0.13 41.87% | 0.23 80.96% | |
days of inventory on hand | ||||||||
days payables outstanding | 260.90 - | |||||||
days sales outstanding | 37.35 - | |||||||
debt to assets | 0.02 - | 0.09 338.38% | 0.26 204.41% | 0.12 55.19% | ||||
debt to equity | 0.02 - | 0.10 391.44% | 0.59 470.56% | 0.15 74.24% | ||||
dividend yield | ||||||||
earnings yield | -0.13 - | -0.17 23.37% | -0.06 62.79% | -0.05 21.99% | -0.05 12.85% | -0.04 21.64% | -0.02 58.48% | |
enterprise value | 5.27M - | 13.46M 155.52% | 76.87M 471.07% | 201.52M 162.14% | 106.73M 47.04% | 83.99M 21.30% | 138.74M 65.18% | |
enterprise value over ebitda | -11.63K - | -4.55 99.96% | -22.12 386.18% | -24.35 10.09% | -18.25 25.06% | -24.04 31.74% | -10.62 55.84% | |
ev to operating cash flow | -7.75 - | -18.14 - | 100.69 655.14% | -23.16 123.00% | ||||
ev to sales | 10.69 - | |||||||
free cash flow per share | -0.03 - | -0.00 - | -0.08 4,350.62% | 0.01 110.30% | -0.08 1,040.05% | |||
free cash flow yield | -0.11 - | -0.00 - | -0.05 8,830.91% | 0.01 113.21% | -0.04 672.84% | |||
graham net net | 0.03 - | 0.08 142.66% | 0.08 4.72% | 0.13 58.37% | 0.07 44.15% | 0.05 35.78% | 0.19 317.28% | |
graham number | 0.24 - | 0.37 55.82% | 0.41 9.74% | 0.68 67.15% | 0.42 39.23% | 0.27 34.64% | 0.42 54.36% | |
income quality | 0.80 - | 0.96 - | -0.22 122.44% | 2.20 1,118.58% | ||||
intangibles to total assets | 0.30 - | 0.09 68.11% | 0.08 15.80% | 0.04 44.18% | 0.06 26.65% | 0.04 26.14% | 0.03 34.73% | |
interest coverage | -3.89K - | -5.82K 49.73% | -852.79 85.35% | -336.12 60.59% | -108.72 67.65% | -116.46 7.12% | ||
interest debt per share | 0.00 - | 0.00 40.01% | 0.00 32,622.59% | 0.01 216.02% | 0.04 293.73% | 0.04 7.30% | ||
inventory turnover | ||||||||
invested capital | 0.02 - | 0.10 391.44% | 0.59 470.56% | 19.63M 3,301,550,628.45% | ||||
market cap | 6.29M - | 17.84M 183.86% | 82.28M 361.10% | 210.99M 156.43% | 112.79M 46.54% | 90.92M 19.39% | 154.44M 69.86% | |
net current asset value | 799.11K - | 4.12M 415.98% | 5.04M 22.33% | 9.26M 83.50% | 5.64M 39.03% | 3.83M 32.10% | 16.41M 328.32% | |
net debt to ebitda | 2.25K - | 1.48 99.93% | 1.56 5.06% | 1.15 26.42% | 1.04 9.49% | 1.98 91.33% | 1.20 39.41% | |
net income per share | -0.04 - | -0.06 53.71% | -0.08 31.22% | -0.14 75.23% | -0.08 43.76% | -0.05 38.88% | -0.03 31.87% | |
operating cash flow per share | -0.03 - | -0.08 - | 0.01 113.72% | -0.07 793.96% | ||||
payables turnover | 1.40 - | |||||||
receivables turnover | 9.77 - | |||||||
research and ddevelopement to revenue | 1.94 - | |||||||
return on tangible assets | -0.74 - | -0.65 13.30% | -0.92 42.12% | -0.99 7.53% | -0.76 22.64% | -0.35 54.06% | -0.12 66.62% | |
revenue per share | 0.02 - | |||||||
roe | -0.66 - | -0.64 2.69% | -0.92 42.99% | -1.01 9.90% | -0.87 14.35% | -0.76 12.55% | -0.15 80.52% | |
roic | -0.66 - | -0.64 2.61% | -0.92 43.00% | -0.97 5.33% | -0.71 26.25% | -1.24 73.61% | -0.19 84.34% | |
sales general and administrative to revenue | 0.40 - | |||||||
shareholders equity per share | 0.06 - | 0.10 57.95% | 0.09 8.23% | 0.14 59.44% | 0.09 34.34% | 0.07 30.11% | 0.23 249.72% | |
stock based compensation to revenue | ||||||||
tangible asset value | 799.11K - | 4.12M 415.98% | 5.04M 22.33% | 9.57M 89.81% | 6.60M 31.05% | 4.64M 29.79% | 17.86M 285.40% | |
tangible book value per share | 0.04 - | 0.09 126.47% | 0.08 6.45% | 0.14 66.27% | 0.09 35.72% | 0.06 32.06% | 0.22 272.34% | |
working capital | 799.11K - | 4.12M 415.98% | 5.04M 22.33% | 9.30M 84.37% | 6.21M 33.17% | 4.20M 32.46% | 18.45M 339.61% |
All numbers in (except ratios and percentages)